Glaucoma: Spotting It Early Is Crucial
Medically reviewed by Drugs.com.
By Cara Murez HealthDay Reporter
FRIDAY, July 14, 2023 -- Treatment can control the symptoms of the most common type of glaucoma and save someone’s vision.
The catch is that a person can’t feel the changes in eye pressure that can damage vision, so they often won’t know they even have it before it’s too late.
That is, unless they’ve been seeing an eye doctor regularly.
One vision expert encourages people to not wait for that pressure to damage the optic nerve, but rather to preserve vision with regular health care.
“Some people say they don’t need glasses, so they don’t need to see an eye doctor,” said Dr. Tara O’Rourke, an optometrist at Penn State Health Eye Center. “It’s important for everyone to have yearly eye exams to monitor the health of the eye, especially for patients over the age of 50.”
About 3 million Americans have glaucoma, according to the U.S. Centers for Disease Control and Prevention. The condition is the second leading cause of blindness in the world.
Half of those who have the most common type, open-angle glaucoma, don’t know they have it.
In open angle glaucoma, the tiny canals that naturally drain away eye fluid become clogged.
“The exact cause or mechanism of open angle glaucoma is unknown at this time. We can manage the eye pressure, but do not have a cure for the disease,” O’Rourke said in a center news release. However, treatment can control glaucoma.
Both heredity and age can contribute to the condition. O’Rourke recommends that people over 50 get tested for glaucoma at least annually, even with perfect vision. A person who has a family member with glaucoma should test earlier.
Some can experience pain, cloudy vision and a sensitivity to light, but many have no symptoms early in the disease. Rather, they have a slow progressive peripheral vision loss, which is irreversible.
Eventually, people with this condition will have total vision loss without treatment. Yet, glaucoma is treatable, especially in the early stages.
To diagnose glaucoma, doctors test to determine eye pressure. Normal pressure is anywhere from 10 millimeters of mercury (mm Hg) to 21 mm Hg. Any measure over 21 is a reason for more testing.
A puff test, in which a machine blows a puff of air into a patient’s eye, is common.
O’Rourke said she typically uses a device called a Goldmann applanation tonometer. With this test, an eye drop numbs the eye, then the device gently taps or rests on the front surface of the eye to get a better reading.
A common treatment is using eyedrops, which will need to continue indefinitely. A variety of drops will have different effects. Some drops decrease fluid production. Others help to improve fluid outflow.
Oral medications can also lower the pressure in the eye, and laser therapy can enhance the outflow of fluid through the drainage system of the eye. Medication will still typically be needed to keep the pressure in the eye down.
Surgical options include installing tiny tubes called stents. These tubes help to clear fluid in the eye. This may happen at the same time as cataract surgery for some patients.
Sources
- Penn State Health, news release, July 6, 2023
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Protect Your Eyes From Summer's Dangers
SATURDAY, June 15, 2024 -- Summertime is primetime for the great outdoors, but that can mean new hazards for your eyes, one expert warned. Simple steps can help cut the risk...
Robotic Procedure Helps Treat Macular Degeneration
THURSDAY, June 12, 2024 -- Robot-guided radiation therapy can improve treatment for age-related macular degeneration, the leading cause of vision loss and blindness among American...
Gene Therapy Improves Vision in People With Inherited Blindness
MONDAY, May 6, 2024 -- An injectable gene therapy caused measurable improvements in vision among a small group of people with inherited blindness, an early-stage clinical trial...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.